Literature DB >> 10334400

Clinical diversity in acute necrotizing encephalopathy.

H Yoshikawa1, T Watanabe, T Abe, Y Oda.   

Abstract

Acute necrotizing encephalopathy is a novel disease entity, proposed by Mizuguchi et al in 1995, that shows a characteristic selective and symmetric involvement of the thalamus, brain stem, and cerebellum. It usually leaves sequelae. The etiology of acute necrotizing encephalopathy is unknown. We describe here six patients aged 6 months to 5 years (four boys and two girls). Four cases were typical, and the patients' cranial computed tomographic scans and magnetic resonance imaging showed irreversible symmetric involvement of the thalamus, brain stem, and cerebellum. Three of the patients died, and one was left with severe sequelae. In the other two patients, who had selective reversible thalamic involvement, the disease was mild; one also showed transient unilateral thalamic involvement. These patients recovered completely. We consider the illness in these two patients to fit the criteria of the mild form of acute necrotizing encephalopathy. We believe that acute necrotizing encephalopathy has some clinical diversity, as is seen in other neurologic disorders, and that a mild form could exist.

Entities:  

Mesh:

Year:  1999        PMID: 10334400     DOI: 10.1177/088307389901400407

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  10 in total

1.  Acute necrotizing encephalopathy: combined therapy and favorable outcome in a new case.

Authors:  Renzo Manara; Malida Franzoi; Paola Cogo; Pier Antonio Battistella
Journal:  Childs Nerv Syst       Date:  2006-03-14       Impact factor: 1.475

2.  Acute necrotizing encephalopathy of childhood: correlation of MR findings and clinical outcome.

Authors:  A M Wong; E M Simon; R A Zimmerman; H-S Wang; C-H Toh; S-H Ng
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

3.  Clinical spectrum and prognostic factors of acute necrotizing encephalopathy in children.

Authors:  Hye-Eun Seo; Su-Kyeong Hwang; Byung Ho Choe; Min-Hyun Cho; Sung-Pa Park; Soonhak Kwon
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

4.  Acute necrotizing encephalopathy in Korean infants and children: imaging findings and diverse clinical outcome.

Authors:  Ji Hye Kim; In-One Kim; Myung Kwan Lim; Man Soo Park; Choong Gon Choi; Hye Won Kim; Jee Eun Kim; Soo Jin Choi; Young Hwan Koh; Dal Mo Yang; Sung Wook Choo; Myung Jin Chung; Hye-Kyung Yoon; Hyun Woo Goo; Munhyang Lee
Journal:  Korean J Radiol       Date:  2004 Jul-Sep       Impact factor: 3.500

5.  Moyamoya disease in a child with previous acute necrotizing encephalopathy.

Authors:  Taik-Kun Kim; Baik-Lin Eun; Sang Hoon Cha; Kyoo Byung Chung; Jung Hyuck Kim; Baek Hyun Kim; Hwan Hoon Chung
Journal:  Pediatr Radiol       Date:  2003-06-12

Review 6.  Update on pediatric dystonias: etiology, epidemiology, and management.

Authors:  Emilio Fernández-Alvarez; Nardo Nardocci
Journal:  Degener Neurol Neuromuscul Dis       Date:  2012-04-11

Review 7.  Acute necrotizing encephalopathy: an underrecognized clinicoradiologic disorder.

Authors:  Xiujuan Wu; Wei Wu; Wei Pan; Limin Wu; Kangding Liu; Hong-Liang Zhang
Journal:  Mediators Inflamm       Date:  2015-03-22       Impact factor: 4.711

Review 8.  Genetic Acute Necrotizing Encephalopathy Associated with RANBP2: Clinical and Therapeutic Implications in Pediatrics.

Authors:  Jesse M Levine; Nusrat Ahsan; Eugenia Ho; Jonathan D Santoro
Journal:  Mult Scler Relat Disord       Date:  2020-05-15       Impact factor: 4.339

9.  COVID-19-Associated Acute Asymmetric Hemorrhagic Necrotizing Encephalopathy: A Case Report.

Authors:  Najo Jomaa; Tarek El Halabi; Jawad Melhem; Georgette Dib; Youssef Ghosn; Mukbil Hourani; Wassim Nasreddine; Ahmad Beydoun
Journal:  Neurohospitalist       Date:  2022-04

10.  Molecular analysis of HLA class II-associated susceptibility to neuroinflammatory diseases in Korean children.

Authors:  Hyun Hee Oh; Soon Hak Kwon; Chang Woo Kim; Byung Ho Choe; Cheol Woo Ko; Hee Du Jung; Jang Soo Suh; Jun Hwa Lee
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.